新冠大流行第二波期间 COVID-19 患者的精神科诊断及相关精神病理学症状的流行率。
Prevalence of psychiatric diagnosis and related psychopathological symptoms among patients with COVID-19 during the second wave of the pandemic.
机构信息
The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing, China.
Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
出版信息
Global Health. 2021 Apr 8;17(1):44. doi: 10.1186/s12992-021-00694-4.
BACKGROUND
The possibility of psychopathological symptoms and related risk factors among normal persons and patients infected during the outbreak of COVID-19 has been widely investigated. The mental health outcomes of the second wave of the pandemic remain unclear, especially those of patients with an infection. Thus, this study aims to explore the prevalence of and related risk factors associated with psychopathological symptoms among patients infected with COVID-19 during the second wave.
METHOD
A cross-sectional survey was conducted in five isolated wards of a designated hospital in Beijing, China, from July 1 to July 15, 2020. The Mini International Neuropsychiatric Interview (MINI) was conducted to assess psychiatric disorders, and a series of scales were used to measure self-reported psychopathological symptoms and psychosomatic factors. Multivariate regression analysis was used to analyze the risk factors associated with psychopathological symptoms.
RESULTS
Among 119 participants with infections, the prevalence of generalized anxiety symptoms (51.3%), depressive symptoms (41.2%), and posttraumatic stress symptoms (PTSS)/posttraumatic stress disorder (PTSD) symptoms (33.6%) was observed. Loneliness, hope, coping strategies, and history of mental disorders were the shared risk or protective factors across several psychopathological symptoms. The perceived impact of COVID-19 is the specific risk factor associated with state anxiety symptoms.
CONCLUSIONS
The prevalence of symptoms of depression, anxiety, and PTSS/PTSD is high among patients with infections during the second wave of the pandemic in Beijing. Clinical doctors must realize that these patients will probably experience depressive disorder, anxiety disorders, and PTSS/PTSD, as well as some neuropsychiatric syndromes. Specific mental health care is urgently required to help patients manage the virus during the second wave of the pandemic.
背景
广泛研究了在 COVID-19 爆发期间正常人和感染者出现精神病理症状的可能性及其相关危险因素。大流行第二波期间患者的心理健康结果尚不清楚，尤其是感染患者的心理健康结果。因此，本研究旨在探讨感染 COVID-19 患者在第二波疫情中出现精神病理症状的流行情况及其相关危险因素。
方法
本研究于 2020 年 7 月 1 日至 7 月 15 日在中国北京的一家指定医院的五个隔离病房进行了横断面调查。采用迷你国际神经精神访谈（MINI）评估精神障碍，采用一系列量表评估自我报告的精神病理症状和身心因素。采用多变量回归分析分析与精神病理症状相关的危险因素。
结果
在 119 名感染者中，观察到广泛性焦虑症状（51.3%）、抑郁症状（41.2%）和创伤后应激症状（PTSS）/创伤后应激障碍（PTSD）症状（33.6%）的患病率。孤独感、希望、应对策略和精神障碍史是几种精神病理症状的共同危险因素或保护因素。对 COVID-19 的感知影响是与状态焦虑症状相关的特定危险因素。
结论
在北京大流行第二波期间，感染患者出现抑郁、焦虑和 PTSS/PTSD 症状的比例较高。临床医生必须认识到这些患者可能会经历抑郁障碍、焦虑障碍和 PTSS/PTSD 以及一些神经精神综合征。在第二波大流行期间，迫切需要提供特定的心理健康护理，以帮助患者管理病毒。
Zotero 插件